Atlas Trials

Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration

Clinical trial NCT02140151 · COMPLETED

Trial details

NCT number
NCT02140151
Sponsor
Southern California Desert Retina Consultants, MC
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Age-related Macular Degeneration
Start date
2014-09-17
Primary completion
2020-07-09
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.